Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesCTWhat are the effects of COVID-19 pneumonia after 5 years?After five years, residual lesions persisted in 35.6% of survivors (37 of 104).Molecular ImagingUSC researchers develop “plug-and-play" platform for PET tracersMRIImage-based grading system estimates nasopharyngeal carcinoma severityASTRO 2026ASTRO 2026 to center on translating radiotherapy data into dialogueSponsor ContentFree webinar for radiology leaders
